美国政府在不完整和推迟的强制性儿科试验新药上的支出

IF 18 1区医学 Q1 PEDIATRICS

JAMA Pediatrics Pub Date : 2025-09-02 DOI:10.1001/jamapediatrics.2025.2817

Ian T. T. Liu, Aaron S. Kesselheim

引用次数: 0

摘要

这项队列研究估计了2015年至2021年美国食品和药物管理局批准的医疗保险D部分、医疗补助计划和医疗保险B部分在儿科药物上的支出。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

US Government Spending on New Drugs With Incomplete and Postponed Mandatory Pediatric Trials

This cohort study estimates Medicare Part D, Medicaid, and Medicare Part B spending on pediatric drugs approved by the US Food and Drug Administration from 2015 to 2021.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JAMA Pediatrics PEDIATRICS-

CiteScore

31.60

自引率

1.90%

发文量

357

期刊介绍： JAMA Pediatrics, the oldest continuously published pediatric journal in the US since 1911, is an international peer-reviewed publication and a part of the JAMA Network. Published weekly online and in 12 issues annually, it garners over 8.4 million article views and downloads yearly. All research articles become freely accessible online after 12 months without any author fees, and through the WHO's HINARI program, the online version is accessible to institutions in developing countries. With a focus on advancing the health of infants, children, and adolescents, JAMA Pediatrics serves as a platform for discussing crucial issues and policies in child and adolescent health care. Leveraging the latest technology, it ensures timely access to information for its readers worldwide.